Table 2.
Results from ROI analysis from the porcine model of stroke.
| Feature | Ipsilateral | Contralateral | p-value |
|---|---|---|---|
| TTPPyruvate (s) | 22 ± 3 | 24 ± 4 | > 0.05 |
| TTPDSC (s) | 9.7 ± 0.9 | 9.7 ± 0.9 | > 0.05 |
| CBVPyruvate (mL/100g) | 7 ± 2 | 6 ± 2 | > 0.05 |
| CBVDSC (mL/100g) | 3.0 ± 0.8 | 1.9 ± 0.4 | > 0.05 |
| CBFPyruvate (mL/100g/min) | 139 ± 12 | 95 ± 5 | 0.003* |
| CBFDSC (mL/100g/min) | 116 ± 24 | 63 ± 40 | 0.03* |
| MTTPyruvate (s) | 31 ± 8 | 60 ± 2 | 0.006* |
| MTTDSC (s) | 3 ± 0.5 | 2.6 ± 0.4 | > 0.05 |
| MCR (/s) | 0.034 ± 0.007 | 0.017 ± 0.02 | 0.03* |
| Lactate:Pyruvate | 1.09 ± 0.07 | 0.70 ± 0.06 | 0.004* |
| FM (%) | 20 ± 6 | 19 ± 11 | > 0.05 |
* Statistically significant.